ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,920 | -81.4% | 10,853 | -63.7% | 0.00% | -100.0% |
| Q3 2019 | $1,047,000 | -33.9% | 29,933 | +6.6% | 0.00% | -50.0% |
| Q2 2019 | $1,585,000 | -23.0% | 28,092 | -0.3% | 0.00% | 0.0% |
| Q1 2019 | $2,059,000 | +9.3% | 28,186 | -4.5% | 0.00% | 0.0% |
| Q4 2018 | $1,883,000 | -37.8% | 29,526 | -2.7% | 0.00% | -33.3% |
| Q3 2018 | $3,029,000 | +39.3% | 30,355 | -0.8% | 0.00% | +50.0% |
| Q2 2018 | $2,174,000 | -7.4% | 30,596 | +35.7% | 0.00% | 0.0% |
| Q1 2018 | $2,347,000 | +15.2% | 22,552 | +11.5% | 0.00% | 0.0% |
| Q4 2017 | $2,038,000 | – | 20,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |